These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 9338469)

  • 41. Regulation of ovarian UT-OC-2 carcinoma cells by cytokines: effects on cell proliferation, activation of transcription factors and apoptosis.
    Seppänen M; Lin L; Saarinen R; Punnonen R; Vihko KK
    Acta Obstet Gynecol Scand; 2008; 87(9):902-9. PubMed ID: 18720042
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Renal cell carcinoma induces interleukin 10 and prostaglandin E2 production by monocytes.
    Ménétrier-Caux C; Bain C; Favrot MC; Duc A; Blay JY
    Br J Cancer; 1999 Jan; 79(1):119-30. PubMed ID: 10408703
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Differential expression of interleukins IL-13 and IL-15 in normal ovarian tissue and ovarian carcinomas.
    Ripley D; Shoup B; Majewski A; Chegini N
    Gynecol Oncol; 2004 Mar; 92(3):761-8. PubMed ID: 14984938
    [TBL] [Abstract][Full Text] [Related]  

  • 44. HLA-G is a potential tumor marker in malignant ascites.
    Singer G; Rebmann V; Chen YC; Liu HT; Ali SZ; Reinsberg J; McMaster MT; Pfeiffer K; Chan DW; Wardelmann E; Grosse-Wilde H; Cheng CC; Kurman RJ; Shih IeM
    Clin Cancer Res; 2003 Oct; 9(12):4460-4. PubMed ID: 14555519
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Granulocyte colony-stimulating factor suppresses autologous tumor killing activity of the peripheral blood lymphocytes in the patients with ovarian carcinoma.
    Ohta Y; Hayakawa S; Karasaki-Suzuki M; Sugita K; Komine S; Chishima F; Hatta Y; Horie T; Seo N; Sheikh A; Nemoto N; Yamamoto T
    Am J Reprod Immunol; 2004 Jul; 52(1):81-7. PubMed ID: 15214947
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The variant hepatocyte nuclear factor 1 activates the P1 promoter of the human alpha-folate receptor gene in ovarian carcinoma.
    Tomassetti A; Mangiarotti F; Mazzi M; Sforzini S; Miotti S; Galmozzi E; Elwood PC; Canevari S
    Cancer Res; 2003 Feb; 63(3):696-704. PubMed ID: 12566316
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ABT-627, a potent endothelin receptor A antagonist, inhibits ovarian carcinoma growth in vitro.
    Salani D; Rosanò L; Di Castro V; Spinella F; Venuti A; Padley RJ; Nicotra MR; Natali PG; Bagnato A
    Clin Sci (Lond); 2002 Aug; 103 Suppl 48():318S-321S. PubMed ID: 12193113
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Lysophospholipids increase interleukin-8 expression in ovarian cancer cells.
    Schwartz BM; Hong G; Morrison BH; Wu W; Baudhuin LM; Xiao YJ; Mok SC; Xu Y
    Gynecol Oncol; 2001 May; 81(2):291-300. PubMed ID: 11330965
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human telomerase reverse transcriptase promoter regulation in normal and malignant human ovarian epithelial cells.
    Braunstein I; Cohen-Barak O; Shachaf C; Ravel Y; Yalon-Hacohen M; Mills GB; Tzukerman M; Skorecki KL
    Cancer Res; 2001 Jul; 61(14):5529-36. PubMed ID: 11454703
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Participation of pigment epithelium of iris and ciliary body in ocular immune privilege. 1. Inhibition of T-cell activation in vitro by direct cell-to-cell contact.
    Yoshida M; Takeuchi M; Streilein JW
    Invest Ophthalmol Vis Sci; 2000 Mar; 41(3):811-21. PubMed ID: 10711698
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells.
    Xu L; Xie K; Mukaida N; Matsushima K; Fidler IJ
    Cancer Res; 1999 Nov; 59(22):5822-9. PubMed ID: 10582705
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Tumor vaccine for ovarian carcinoma targeting sperm protein 17.
    Chiriva-Internati M; Wang Z; Salati E; Timmins P; Lim SH
    Cancer; 2002 May; 94(9):2447-53. PubMed ID: 12015770
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Expression and localization of aquaporin-5 in the epithelial ovarian tumors.
    Yang JH; Shi YF; Cheng Q; Deng L
    Gynecol Oncol; 2006 Feb; 100(2):294-9. PubMed ID: 16242760
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Isolation and characterization of an immunosuppressive acidic protein from ascitic fluids of cancer patients.
    Tamura K; Shibata Y; Matsuda Y; Ishida N
    Cancer Res; 1981 Aug; 41(8):3244-52. PubMed ID: 6166371
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Nonspecific immunosuppressive factors in malignant ascites: further characterization and possible relationship to erythrocyte receptors of human peripheral T cells.
    Oh SK; Moolten FL
    J Immunol; 1981 Dec; 127(6):2300-7. PubMed ID: 6975316
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Mitogen-induced blastogenesis and receptor mobility inhibition by breast cancer serum with elevated orosomucoid (alpha 1-acid glycoprotein) levels.
    Cheresh DA; Distasio JA; Vogel CL; Lopez DM
    J Natl Cancer Inst; 1982 May; 68(5):779-83. PubMed ID: 6951088
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Non-specific normal immunosuppressive protein (Nip): purification and further biochemical characterization.
    Gavison-Goren R; Nelken D
    Immunology; 1983 Aug; 49(4):599-608. PubMed ID: 6192080
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibition of macrophage migration by a factor from ascites fluids of ovarian cancer patients. I. Biochemical characterization and purification.
    Fahlbusch B; Tittel R
    Biomed Biochim Acta; 1986; 45(3):359-70. PubMed ID: 3518710
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Microheterogeneity of alpha 1-acid glycoprotein in the sera of patients with cancer or inflammatory states of the ovaries.
    Katnik I; Gerber J; Dobryszycka W
    Arch Immunol Ther Exp (Warsz); 1988; 36(1):1-6. PubMed ID: 3233059
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Spontaneous release of interleukin-6 by primary cultures of lymphoid and tumor cell populations purified from human ovarian carcinoma.
    Burger RA; Grosen EA; Ioli GR; Van Eden ME; Park M; Berman ML; Manetta A; Disaia PJ; Granger GA; Gatanaga T
    J Interferon Cytokine Res; 1995 Mar; 15(3):255-60. PubMed ID: 7584672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.